
Moderna Inc (NASDAQ:MRNA) shares are trading higher by 9.7% at $149.11 after the company reported better-than-expected fourth-quarter EPS and sales results and announced a new $3 billion buyback.
Moderna reported quarterly earnings of $11.29 per share which beat the analyst consensus estimate of $9.90. The company reported quarterly sales of $7.20 billion which beat the analyst consensus estimate of $6.79 billion by 6%.